IL17A and experimental autoimmune encephalomyelitis: Accordingly, inhibition of IL-23 in mice caused a significant decrease in IL-17A levels (6) and IL-17A-mediated immunopathology such as experimental autoimmune encephalomyelitis (6) and spontaneous colitis in Winnie mice (7).